# Understanding the PIPES Act

This bill would prevent federal government money from being used to buy sterile needles, syringes, or drug paraphernalia like pipes for substance abuse treatment programs. Specifically, it blocks federal funding that was allocated through the American Rescue Plan (a COVID-relief law) from purchasing these items for people struggling with addiction to illegal drugs.

The bill targets two main things: first, sterile needles and syringes used for injecting drugs, and second, any equipment used to smoke, inhale, or consume narcotics. The idea behind the restriction is to avoid using taxpayer money in ways that supporters of the bill believe could enable drug use. However, there's an important exception built in: if a state or local health department determines that their area is facing a serious outbreak of diseases like hepatitis or HIV from injection drug use, they can still use federal funds for needle programs if they work with the CDC and follow all applicable laws.

This bill affects public health programs that receive federal funding and work with people dealing with substance use disorders. Supporters argue it prevents federal money from directly facilitating drug use, while critics contend that needle exchange programs actually reduce disease transmission and save lives and money in the long run. The practical impact would depend on whether local health departments can demonstrate they're facing a disease outbreak—if they can, they'd maintain access to federal funding for these programs despite the bill's restrictions.

PIPES Act

McKinley, David B.

Preventing Illicit Paraphernalia for Exchange Systems Act or the PIPES ActThis bill restricts the use of funding made available through the American Rescue Plan Act of 2021 for community-based overdose prevention programs, syringe services programs, and other harm reduction programs. First, the bill prohibits the use of the act's funding to procure or distribute pipes or other paraphernalia that can be used to smoke, inhale, or ingest narcotics. Second, the bill applies to the act's funding the conditions that apply to other funding from the Department of Health and Human Services for syringe services programs and needle exchange programs. The conditions require that programs (1) operate in a jurisdiction experiencing (or at risk for) increased transmission of hepatitis and HIV infections due to injection drug use, (2) use nonfederal funds for the purchase of syringes or needles, and (3) otherwise follow applicable laws.